The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
June 20th 2025
The expansion of pneumococcal vaccine recommendations would ultimately lead to economic and health benefits, especially for underserved populations.
Biktarvy Demonstrates Efficacy, Viral Suppression in Treatment-Naïve Adults With HIV
July 28th 2021A pooled analysis of a 48-week open-label extension of a pair of phase 3 studies found that 99% of patients with HIV who initiated treatment using bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide 25 mg tablets maintained an undetectable viral load through 4 years of follow-up.
Read More
One dose of AstraZeneca’s COVID-19 vaccine (Vaxzevria) was 82% effective against hospitalization or death caused by either the Beta or Gamma variants of the SARS-CoV-2 virus, according to data from the Canadian Immunization Research Network, currently published as a pre-print.
Read More
FDA Approves Expansion of Shingrix for Prevention of Herpes Zoster in Immunocompromised Adults
July 26th 2021Zoster vaccine recombinant, adjuvanted has been approved by the FDA for the prevention of herpes zoster in adults 18 years of age and older who are, or will be, at an increased risk of shingles because of immunodeficiency or immunosuppression.
Read More
Survey Finds 3 in 10 Americans Increased Supplement Use Since COVID-19 Pandemic
July 23rd 2021A new survey conducted by The Harris Poll on behalf of the Samueli Foundation found that 29% of Americans are taking more supplements compared with before the COVID-19 pandemic, bringing the nationwide percentage of supplement-takers to 76%.
Read More